ALPHA
03030.265
0.265
0.000 (0.0%)| High | 0.270 |
| Low | 0.255 |
| Open | 0.265 |
| Volume | 8,972,800 |
| Volume (B/S) | 1,470,100 / 892,500 |
| Price Bid/Ask | 0.260 / 0.265 |
| 52w | 0.255 - 0.345 |
| ROE | 28.50 |
| P/E | 23.31 |
| EPS | 1.14 |
| DPS | 1.00 |
| DY | 3.77% |
| NTA | 0.0400 |
| P/B | 6.63 |
| RPS | 3.91 |
| PSR | 6.78 |
| Market Cap | 1,287.9M |
| Shares (mil) | 4,860.00 |
| RQoQ RYoY |
| CAGR |
3Y
-53.5%
TTM
24%
5Y
17.1%
TTM
-18.8%
|
|
| RSI(14) | Neutral 30.9 |
| Stochastic(14) | Neutral 40.0 |
| Stochastic RSI(14) | Neutral 48.7 |
| Average Volume (3M) | 1,598,200 |
| Relative Volume | 0.0 |
| Announced | Financial Year | Subject | EX Date | Payment Date | Amount | Indicator | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31 May, 2026 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 22 Jan 2026 | 31 May 2026 | Interim Dividend | 18 Mar 2026 | 31 Mar 2026 | 0.0050 | Currency | View | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 31 May, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 28 Jul 2025 | 31 May 2025 | Interim Dividend | 08 Aug 2025 | 29 Aug 2025 | 0.0050 | Currency | View | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 03 Dec 2024 | 31 May 2025 | Interim Dividend | 17 Dec 2024 | 31 Dec 2024 | 0.0050 | Currency | View | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 31 May, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 17 Jul 2024 | 31 May 2024 | Interim Dividend | 30 Jul 2024 | 15 Aug 2024 | 0.0045 | Currency | View | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Announced | EX Date | Subject | Ratio | Offer |
|---|
No records
| Name | Price | Change | Volume | Gearing | Premium | Premium % | Maturity |
|---|
No warrants found.
Recent News
-
Alpha IVF says worst of start-up pains is over, still eyes regional expansion
FERTILITY care specialist Alpha IVF Group Bhd (KL:ALPHA) is doubling down on regional expansion and expects earnings to return to the growth path later this year as start-up-related costs ease and its newly launched in-vitro fertilisation (IVF) centres begin to contribute to profit. Aft...TheEdge -
3利好发酵 中小型股购兴回温
（吉隆坡3日讯）在国内经济基本面稳健、外国直接投资（FDI）持续流入及投资者积极寻求超额回酬的推动下，分析员看好估值具吸引力的中小型股在2026年有望受惠于多项独特催化剂及资金轮动，迎来更亮眼表现。受惠多项独特催化剂及资金轮动兴业研究分析员指出，上周四（29日）举行的第六场兴业小型股企业线上接洽活动（SCCA）反应热烈，吸引约70名来自亚洲各地的基金经理和分析员参与，显示市场对中小型股的兴趣正在回温。“本次活动汇集一批相对低调、希望加强与投资者互动的公司，同时也包括我们看好的部分中小型股，...Sinchew -
诸多利好烘托业务展望 估值诱人小型股可突围
兴业投行研究指出，在宏观环境趋稳、美元走软及市场资金轮动背景下，估值具吸引力的小型股，有望在2026年迎来表现窗口。...Nanyang -
Positive outlook for Alpha IVF’s growth
PETALING JAYA: Despite the anticipated near-term softness in its financial year ending May 31, 2026 (FY26), arising from pre-operating startup costs for its four new in vitro fertilisation (IVF) centres, analysts remain optimistic about Alpha IVF Group Bhd's outlook for FY27.TheStar -
今日选股｜阿儿法国际支出增 3年财测遭下调
券商 ：达证券投资建议 ：买进目标价 ：37仙闭市价 ：29仙（截至1月23日）每股收益 ：1.2仙（2026财年估计）本益比 ：25.1倍（2026财年估计）股息收益率：3.2%（2026财年估计）我们下调阿儿法国际（ALPHA，0303，创业板医疗保健）的销售预测4%，考虑到行政支出预期更高，因此将2026至2028财年的盈利预测调整至5710万令吉、7220万令吉及8400万令吉，低于此前预测的6950万令吉、8320万令吉及9450万令吉。同时，我们在维持2027年本益比...Chinapress
Recent Announcements
-
Immediate Announcement on Shares Buy Back
-
Changes in Director's Interest (Section 219 of CA 2016) - DR NG PENG WAH
-
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DR NG PENG WAH
-
Changes in Director's Interest (Section 219 of CA 2016) - DATO' DR LEE SOON SOO
-
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DATO DR LEE SOON SOO
